Romania: medical and donor requirements
The short answer
Romania has binding rules for some parts of assisted reproduction: facilities carrying out specified reproductive-cell activities must meet accreditation criteria, and technical rules address donor selection, infection testing, genetic-risk information and, for non-partner sperm donation, quarantine. Patient-rights legislation also governs information and consent.
Those rules do not, by themselves, answer whether a proposed surrogacy arrangement is lawful or enforceable. Romanian law sets no complete statutory medical checklist for a gestational carrier, nor a universal numeric age limit for every donor, carrier or intended parent. This is a limited finding, not proof that no later or separate rule exists. Before a programme starts, verify the current law and the clinic's exact authorisation with a Romanian lawyer and the relevant health authorities.
Which legal sources answer which question?
The Romanian Civil Code, Articles 441–447, addresses medically assisted human reproduction using a third-party donor, particularly filiation, consent and confidentiality. The Technical Requirements adopted in 2007 address reproductive-cell donor selection and laboratory safety; the official legislative portal displays a consolidated version of that instrument with an amendment history through 29 April 2017. Ministry of Health Order No. 860/2013, as amended by Order No. 273/2020, sets accreditation criteria for facilities performing listed reproductive-cell or tissue activities. Patient Rights Law No. 46/2003 supplies general rules on medical information and refusal of treatment.
These instruments have different jobs. A donor-screening rule is not a surrogacy authorisation; a clinic accreditation is not a ruling on parentage; and a clinic's own medical protocol is not automatically a statutory requirement. The separate informational consolidation used for some Annex III wording is dated 25 March 2013, while the official portal record shows a consolidated history through 29 April 2017. Neither record alone proves that no later change applies; confirm the operative text before relying on technical donor requirements.
Third-party gametes: consent and filiation under the Civil Code
The text of Article 441 says that medically assisted reproduction with a third-party donor does not create a parent-child filiation link between the child and the donor, and that an action in liability cannot be brought against the donor under that provision. For the purposes of this section, the Code describes the intended parents as a man and a woman or a single woman. Do not stretch this limited provision into a conclusion about the status of a gestational carrier, the validity of a surrogacy contract or recognition of parentage abroad.
The text of Article 442 provides for prior confidential consent before a notary public, who must expressly explain the filiation consequences. It also states that consent becomes ineffective if, before conception, a parent dies, a divorce petition is filed or the couple factually separates; written revocation is possible at any time, including before the treating physician. However, Article 447 says the legal regime of third-party-donor ART, confidentiality and transmission of information are to be established by special law. The sources do not establish whether a currently operative special statute fully implements that referral. Before treating the notarial step or related Code provisions as settled operational requirements, ask Romanian counsel to confirm the current applicable law and procedure for the exact treatment. A clinic form alone does not resolve that legal question.
The text of Article 445 treats information about medically assisted reproduction as confidential. It provides a court-authorised route for confidential disclosure to a doctor or competent authority where withholding information creates a risk of serious harm to the health of the person conceived or descendants. Confidentiality therefore matters, but the article recognises a narrow health-protection route; it is not a general entitlement to obtain donor identity.
What an accredited reproductive-medicine facility must demonstrate
Annex 7 to Order No. 860/2013, inserted by Order No. 273/2020, sets activity-specific accreditation criteria. The facility must have a health operating authorisation, and its premises, equipment and staff must match the activities it seeks to perform. The criteria address such matters as reproductive-cell collection, testing and processing, storage, embryo handling or use, laboratory equipment, qualified medical and laboratory personnel, quality management, emergency arrangements, sample identification and traceability.
Accreditation is activity-specific, not a blanket certificate for every fertility service. Ask to see the current authorisation and accreditation decision, and compare the authorised activities with the actual plan: collection of eggs or sperm, laboratory testing and processing, cryostorage, transport, embryo handling and transfer. A clinic's website, marketing statement or former accreditation list is not enough to confirm its current status. The text cited is the 2020 amendment; later amendments and the clinic's present status need direct confirmation.
How non-partner gamete donors are assessed
The accessible text of the Technical Requirements of 12 October 2007, Annex III, section 2, says that donors of reproductive cells used other than in donation between partners are selected by reference to age, health and medical history. The process includes a medical-history questionnaire and an interview by qualified medical personnel. The assessment must consider risks to the donor, including risks associated with ovarian stimulation or superovulation, sedation, egg retrieval and possible psychological consequences.
This is a risk-based assessment, not a guarantee that a child will have no health condition. The provisions reviewed do not give one universal numeric age threshold for all donors. They also distinguish partner donation and certain direct-use situations from non-partner donation. Ask the clinic which route applies to the actual sample and which current legal provision and written protocol it uses; do not assume every pathway has identical testing or documentation.
Infection testing and risk-based additional tests
For non-partner reproductive-cell donation, the accessible Annex III text specifies negative tests for HIV types 1 and 2, hepatitis B, hepatitis C and syphilis. For sperm donors, it additionally specifies a negative Chlamydia test on a urine sample using nucleic-acid amplification testing (NAT). The text calls for HTLV-I antibody testing when the donor lives in or comes from a high-prevalence area, has a sexual partner from such an area, or has parents from such an area.
Additional tests may be required depending on the donor's medical history, travel and the characteristics of the donated cells; the text gives malaria, cytomegalovirus (CMV) and Trypanosoma cruzi as examples. These are not a universal extra panel for every person. Ask for the actual dated laboratory results, the test method and an explanation of any risk-based addition or omission. A verbal statement that the donor was “fully screened” is less useful than a documented record.
The 180-day rule for non-partner sperm donation
The accessible technical requirements state that sperm donations other than donations between partners are to be kept in quarantine for at least 180 days, after which repeat testing is required. The same text specifies exceptions: a repeat sample is not required where the blood sample also receives NAT testing for HIV, hepatitis B and hepatitis C, or where processing includes a validated inactivation step for the relevant viruses.
This is a specific rule for non-partner sperm donation. Do not automatically apply it to eggs, embryos, partner donation or every direct-use procedure. Because the accessible consolidated text is dated through 25 March 2013, the clinic and a Romanian lawyer should confirm the currently operative version and the precise exception relied on before a cycle begins.
Genetic risk, disclosure and records
The accessible technical requirements call for genetic screening after consent, taking the donor's family history into account and assessing known inherited characteristics where they are present in the family. The recipient must be given a clear explanation of the relevant risks and the measures used to reduce them. The text does not establish one single genetic panel that is suitable for every donor and every family.
Ask what family-history information was collected, which tests were performed, what remains uncertain and how residual risks were explained. The Civil Code's confidentiality provisions also matter: the intended parents may not be entitled to all identifying donor information. Agree in advance what non-identifying medical information will be retained and made available if a future health concern arises, and how the clinic will respond to a legally authorised request.
Gestational-carrier assessment and patient consent
The reviewed provisions do not set out a complete surrogacy-specific medical eligibility checklist for a gestational carrier or intended parent. They therefore do not establish, in these sources, a uniform statutory age limit, a BMI threshold, a statutory threshold for the number of previous births, a specific psychological assessment protocol or a mandatory medical test panel for a gestational carrier. Such criteria may appear in a clinic's written protocol or professional practice, but that does not make them statutory rules. Conversely, absence from the sources is not proof that no other current rule applies.
General patient-rights duties still matter. Under Law No. 46/2003, a patient is entitled to information about proposed interventions, potential risks and available alternatives, including the option of not undergoing treatment. Information should be clear and, where needed, provided in a language the patient understands. Article 13 allows a patient to refuse or stop an intervention, with the consequences explained and the decision recorded in writing. These general rights do not replace a separate legal review of a surrogacy arrangement.
Binding rules versus clinic policy: a practical distinction
Use the distinction below when a clinic describes a condition as “required by Romanian law.” Ask for the exact provision or written protocol rather than relying on an unexplained statement.
| Issue | What the reviewed law says | What to ask the clinic |
|---|---|---|
| Facility status | Specified reproductive-cell activities have accreditation criteria and require the relevant health authorisation. | Show the current documents and the exact activity scope. |
| Gamete donor | The accessible technical text requires age/health/history assessment and specified infection tests for non-partner donation. | Provide the current protocol, dated tests and reasons for any extra or omitted tests. |
| Gestational carrier | No complete statutory carrier checklist exists. | Identify each criterion's legal basis or label it as clinic policy/medical judgment. |
| Surrogacy outcome | Clinic accreditation and donor screening do not settle surrogacy legality, contract enforceability or parentage. | Obtain an independent written Romanian-law opinion before signing or paying. |
Checklist before consenting, paying or starting a cycle
1. Verify the facility. Request its current health operating authorisation and accreditation, including the activities actually covered. If samples will be transported or stored elsewhere, identify every facility and its role.
2. Get the clinical pathway in writing. Ask for the proposed treatment steps, who performs each step, what happens if a test is positive or inconclusive, how emergencies are handled and how adverse events are reported. Ask the treating team to distinguish statutory requirements from its own clinical criteria.
3. Audit the donor record. Request a list of infectious tests and dates, any required repeat test or quarantine record, the family-history and genetic-risk process, and a written explanation of relevant residual risks. Respect donor confidentiality; request non-identifying medical information where identifying data cannot lawfully be disclosed.
4. Read the consent documents before signing. Confirm that the risks, alternatives, costs and option to stop are explained in a language you understand. Where Civil Code Article 442 applies to third-party-donor ART, ask how prior notarial consent is arranged and documented.
5. Obtain independent legal advice on the actual programme. Ask a Romanian lawyer to confirm the current status of any special ART or surrogacy legislation, the legal role of the gestational carrier, contract enforceability, parentage steps and the implications for any cross-border plans. Do this before making a non-refundable payment or beginning treatment.
A decision gate before treatment
Do not move from research to treatment until the clinic provides current authorisation and accreditation documents, a written medical pathway, the applicable donor-screening record and understandable consent documents. Before signing or paying, obtain a separate written opinion from a Romanian lawyer that identifies the current legal basis for the proposed surrogacy arrangement, not merely for the laboratory or donor procedures.
The remaining checks are whether the technical donor requirements changed after the official portal's consolidated history through 29 April 2017, how Article 447's special-law referral currently applies, and whether later legislation changes the legal position on surrogacy. Clinic policy cannot resolve these legislative questions. The written opinion should identify the official provisions checked and the date of verification.
Only after those legal and facility checks should the treating team assess individual medical suitability. Keep five issues separate: the carrier's medical eligibility, gamete safety, informed consent, enforceability of the agreement and legal parentage.
Primary Romanian legal sources
- Romanian Civil Code (official legislative portal), Articles 441–447 — Official legislative portal excerpts for Civil Code Arts. 441–447; full-page retrieval was limited.
- Informational consolidated text of the Technical Requirements of 12 October 2007 (reproductive-cell donor Annex III) — Technical requirements for reproductive-cell donation; the accessible consolidation states it was updated through 25 March 2013.
- Ministry of Health Order No. 273/2020 amending Order No. 860/2013, Annex 7 accreditation criteria for reproductive-cell/tissue activities — Order No. 273/2020 adding accreditation criteria to Order No. 860/2013, Annex 7.
- Patient Rights Law No. 46/2003, consolidated text — Patient Rights Law No. 46/2003; consolidated portal text includes changes through 14 March 2026.
- LawChat consolidated Romanian Civil Code text (secondary source; consolidated through 3 May 2026) — Secondary consolidated text through 3 May 2026; not an official source.
- Order No. 1,763/2007: Technical Requirements published in Monitorul Oficial No. 698 of 16 October 2007 (official portal record) — Official portal record identifies the original 2007 order and its Official Gazette publication; full-page retrieval was limited.
